Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 301

1.

Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.

He Q, Martinez-Sobrido L, Eko FO, Palese P, Garcia-Sastre A, Lyn D, Okenu D, Bandea C, Ananaba GA, Black CM, Igietseme JU.

Immunology. 2007 Sep;122(1):28-37. Erratum in: Immunology. 2007 Oct;122(2):302.

3.

Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.

Eko FO, Lubitz W, McMillan L, Ramey K, Moore TT, Ananaba GA, Lyn D, Black CM, Igietseme JU.

Vaccine. 2003 Apr 2;21(15):1694-703.

PMID:
12639492
6.
7.

Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.

Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD.

J Exp Med. 1998 Sep 7;188(5):809-18.

8.

Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.

Hickey DK, Aldwell FE, Beagley KW.

Vaccine. 2009 Oct 19;27(44):6217-25. doi: 10.1016/j.vaccine.2009.08.001.

PMID:
19698810
9.

A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.

Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO.

FEMS Immunol Med Microbiol. 2007 Feb;49(1):46-55.

10.

Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.

Brown TH, David J, Acosta-Ramirez E, Moore JM, Lee S, Zhong G, Hancock RE, Xing Z, Halperin SA, Wang J.

Vaccine. 2012 Jan 5;30(2):350-60. doi: 10.1016/j.vaccine.2011.10.086.

PMID:
22075089
11.

Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.

Li Z, Wang S, Wu Y, Zhong G, Chen D.

Sci China C Life Sci. 2008 Nov;51(11):973-80. doi: 10.1007/s11427-008-0130-9.

PMID:
18989639
12.

Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.

Li W, Guentzel MN, Seshu J, Zhong G, Murthy AK, Arulanandam BP.

Clin Vaccine Immunol. 2007 Dec;14(12):1537-44.

14.

Induction of immune memory by a multisubunit chlamydial vaccine.

Eko FO, Ekong E, He Q, Black CM, Igietseme JU.

Vaccine. 2011 Feb 4;29(7):1472-80. doi: 10.1016/j.vaccine.2010.12.024. Erratum in: Vaccine. 2011 Apr 27;29(19):3623-4.

15.

Chlamydia vaccines: strategies and status.

Igietseme JU, Black CM, Caldwell HD.

BioDrugs. 2002;16(1):19-35. Review.

PMID:
11908999
17.

Fc receptor regulation of protective immunity against Chlamydia trachomatis.

Moore T, Ananaba GA, Bolier J, Bowers S, Belay T, Eko FO, Igietseme JU.

Immunology. 2002 Feb;105(2):213-21.

18.

A novel recombinant multisubunit vaccine against Chlamydia.

Eko FO, He Q, Brown T, McMillan L, Ifere GO, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Igietseme JU.

J Immunol. 2004 Sep 1;173(5):3375-82.

19.

Validation of the Chlamydia trachomatis genital challenge pig model for testing recombinant protein vaccines.

Schautteet K, Stuyven E, Cox E, Vanrompay D.

J Med Microbiol. 2011 Jan;60(Pt 1):117-27. doi: 10.1099/jmm.0.024448-0.

PMID:
20847123
Items per page

Supplemental Content

Support Center